Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last hours
Enjoy this offer
* See conditions under "Our services"

Valuation: Pharmaids Pharmaceuticals Limited

Market Cap 976M 10.34M 9.02M 8.35M 7.82M 14.66M 14.75M 99.07M 38.4M 480M 38.82M 37.99M 1.67B P/E 2024
-14.8x
P/E 2025 -22.5x
Enterprise Value 1.34B 14.25M 12.42M 11.5M 10.77M 20.2M 20.32M 136M 52.89M 662M 53.47M 52.33M 2.3B EV / Sales 2024
12,382,225x
EV / Sales 2025 14,298,457x
Free-Float
25.74%
Yield 2024 *
-
Yield 2025 -
05-29 Pharmaids Pharmaceuticals Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026 CI
02-12 Pharmaids Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2025 CI
01-05 Pharmaids Pharmaceuticals Limited Announces Completion of Term of Mopperthy Sudheer as Independent Director and Member of the Audit Committee and Nomination & Remuneration Committee, Effective January 5, 2026 CI
01-02 Pharmaids Pharmaceuticals Limited Appoints Dr. Yogananda Moolemath as Independent Director, Effective January 1, 2026 CI
11-28 Pharmaids Pharmaceuticals appoints P N Vijay as chairman effective December 5, 2025 RE
11-28 Pharmaids Pharmaceuticals Limited Announces Board and Committee Changes CI
11-11 Pharmaids Pharmaceuticals Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2025 CI
18/09/25 Sourabh Hadimani completed the acquisition of 66.50% stake in Anugraha Chemicals P. Ltd. from Pharmaids Pharmaceuticals Limited. CI
18/08/25 Shankarappa Nagaraja Vinaya Babu completed the acquisition of 7.68% stake in Pharmaids Pharmaceuticals Limited for approximately INR 170 million. CI
07/08/25 Pharmaids Pharmaceuticals Limited Announces Executive Changes, Effective August 7, 2025 CI
07/08/25 Pharmaids Pharmaceuticals Limited Announces Resignation of S Prasad as the Chief Executive Officer Effective August 07, 2025 CI
07/08/25 Pharmaids Pharmaceuticals CEO S Prasad resigns RE
07/08/25 Pharmaids Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended June 30, 2025 CI
1 day-2.13%
1 week+12.80%
Current month+6.03%
1 month+9.35%
3 months-3.16%
6 months-35.27%
Current year-32.50%
1 week 27.67
Extreme 27.67
34.2
1 month 25.6
Extreme 25.6
34.2
Current year 25.6
Extreme 25.6
50.9
1 year 25.6
Extreme 25.6
70
3 years 25.6
Extreme 25.6
87.46
5 years 10.17
Extreme 10.17
87.46
10 years 2.15
Extreme 2.15
87.46
Manager TitleAgeSince
Director of Finance/CFO - 13/10/2022
Chief Tech/Sci/R&D Officer - 07/08/2025
Compliance Officer - 14/08/2024
Director TitleAgeSince
Director/Board Member - 09/07/2022
Director/Board Member - -
Chairman 74 05/12/2025
Change 5-day change 1-year change 3-year change Capi.($)
-2.13%+12.80%-43.75%+7.23% 12.3M
+32.62%-5.37%+39.94%+145.38% 980B
-3.20%-4.17%+51.52%+39.07% 550B
-2.14%-3.68%+16.71%+56.15% 382B
-1.75%+0.25%+25.86%+16.53% 317B
+0.61%-1.69%+25.42%+13.64% 270B
+0.22%-3.10%+24.25%+30.21% 269B
+4.59%+1.98%-40.02%-45.89% 191B
-1.90%-4.65%+16.56%+47.00% 182B
-1.35%-1.68%+14.59%+56.94% 154B
Average -0.66%-0.89%+13.11%+36.63% 329.41B
Weighted average by Cap. -0.97%-3.38%+28.25%+64.05%

Financials

2024 2025
Net sales 151.12 1.6 1.4 1.29 1.21 2.27 2.28 15.34 5.95 74.38 6.01 5.88 258.28 195.14 2.07 1.8 1.67 1.56 2.93 2.95 19.81 7.68 96.05 7.76 7.6 333.51
Net income -79.68M -844K -736K -682K -638K -1.2M -1.2M -8.09M -3.14M -39.22M -3.17M -3.1M -136M -108M -1.14M -996K -922K -863K -1.62M -1.63M -10.94M -4.24M -53.04M -4.29M -4.2M -184M
Net Debt 37.29M 395K 345K 319K 299K 560K 564K 3.79M 1.47M 18.35M 1.48M 1.45M 63.73M 368M 3.9M 3.4M 3.15M 2.95M 5.53M 5.57M 37.39M 14.49M 181M 14.65M 14.34M 629M
Logo Pharmaids Pharmaceuticals Limited
Pharmaids Pharmaceuticals Limited is an India-based suppliers of a range of specialty chemicals, skin care, hospital care and generic products in the areas of orthopedic, neuro and gastro, and other. The Company is engaged in the business of trading and manufacturing of generics, bulk drugs, and intermediaries, and other. The Company operates through Bulk Drugs and Intermediates segment. Its specialty chemicals products include Retinol, DL Alpha Tocopherol, D Pantothenate, Cyanocobalamin, Pyridoxine Hcl, Thiamine, Nicotinic Acid, Water Sol. Vitamin E, Coenzyme Q10 and D-Biotin. Its skin care products include Best care hands, Hands Sanitizer, Moisturizing Cream, Skinsure Plus, SkinSure Ultra, Alcohol Gel and Barrier Cream. Its hospital care products include Xepi Rub M, Facein Spray, Sod Hypochlorite, Sanmedin, Strumen G, Strumen TRIACID, Facein Eco, Facein Power 256, Facein Spray, Sod Hypochlorite, Wipes and PPE. Its generic products include Linzomust, Benfoshine, Duojoint, and other.
Employees
28
Date Price Change Volume
19/06/26 32.17 -2.13% 13,823
18/06/26 32.87 +1.83% 10,926
17/06/26 32.28 +12.32% 25,178
16/06/26 28.74 -2.31% 8,953
15/06/26 29.42 +1.59% 11,210
  1. Stock Market
  2. Stocks
  3. PHARMAID Stock
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!